An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue
Article Abstract:
The drug atosiban can delay premature labor for up to seven days, according to a study of 501 pregnant women in premature labor. This drug inhibits oxytocin, a hormone that make the uterus contract. The drug is sold under the trade name Antocin.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Maintenance treatment of preterm labor with the oxytocin antagonist atosiban
Article Abstract:
The drug atosiban may prevent premature birth if given as a continuous intravenous infusion to pregnant women who have had one episode of premature labor. This was the conclusion of a study of 513 pregnant women who received atosiban to stop premature labor and continued to receive the drug or a placebo until the end of the pregnancy.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions
Article Abstract:
Intravenous infusions of the drug atosiban may be useful in decreasing uterine contractions in pregnant women experiencing premature labor. Researchers studied the effect of atosiban on eight women experiencing premature labor contractions between 20 and 36 weeks of pregnancy. Blood samples revealed that the maximum concentration of atosiban occurred one hour after infusions began. Uterine contractions diminished by 65% in the second hour after infusion. Atosiban was quickly cleared from the blood after the infusions ended, as its half-life was about 18 minutes.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A. - U.S.S.R. double-blind, placebo-controlled trial
- Abstracts: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting
- Abstracts: Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
- Abstracts: Effectiveness of a violence prevention curriculum among children in elementary school: a randomized controlled trial
- Abstracts: A comparison of heat-induced hyperactivation in patients' sperm after colloid or pentoxifylline wash methods. Type 5 phosphodiesterase regulation of human sperm motility